Catalyst Wire Dossier Catalyst Wire Dossier
EMA approval · 2026-07-08

EMA Authorised: Ritonavir Viatris (previously Ritonavir Mylan) (ritonavir) — Viatris Limited

View source ↗

Summary

Ritonavir Viatris (ritonavir) has been authorised in the EU for HIV infections.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ritonavir (Ritonavir)
  • Ritonavir Viatris (ritonavir)

Snippet

Status: Authorised. Therapeutic area: HIV Infections. MAH: Viatris Limited. Decision date: 05/05/2026